Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.210
+0.070 (6.14%)
At close: Apr 28, 2026, 4:00 PM EDT
1.364
+0.154 (12.70%)
Pre-market: Apr 29, 2026, 7:16 AM EDT

Traws Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
9.17-166.52-18.95-18.96-16.16
Upgrade
Depreciation & Amortization
0.060.010.020.010.01
Upgrade
Asset Writedown & Restructuring Costs
-117.46---
Upgrade
Stock-Based Compensation
0.731.391.31.170.58
Upgrade
Other Operating Activities
-26.5724.44---0.32
Upgrade
Change in Accounts Receivable
-2.03-1.750.01-00.01
Upgrade
Change in Accounts Payable
-0.610.651.761.1-2.08
Upgrade
Change in Unearned Revenue
-2.79-0.23-0.23-0.23-0.23
Upgrade
Change in Other Net Operating Assets
3.86-5.25-1.850.61-1.3
Upgrade
Operating Cash Flow
-18.19-29.79-17.93-16.29-19.49
Upgrade
Capital Expenditures
---0.01--
Upgrade
Cash Acquisitions
--3.65---
Upgrade
Sale (Purchase) of Intangibles
-2.59----
Upgrade
Investing Cash Flow
-2.59-3.65-0.01--
Upgrade
Issuance of Common Stock
5.6133.98--55.56
Upgrade
Other Financing Activities
-2.4----
Upgrade
Financing Cash Flow
3.233.98--55.56
Upgrade
Foreign Exchange Rate Adjustments
0.05-0.020.01-0.02-0.03
Upgrade
Net Cash Flow
-17.520.52-17.94-16.3136.05
Upgrade
Free Cash Flow
-18.19-29.79-17.95-16.29-19.49
Upgrade
Free Cash Flow Margin
-651.79%-13182.30%-7940.71%-7209.74%-8622.57%
Upgrade
Free Cash Flow Per Share
-2.21-19.19-21.38-19.48-28.94
Upgrade
Levered Free Cash Flow
-13.9-13.63-11.46-9.38-13.23
Upgrade
Unlevered Free Cash Flow
-13.9-13.63-11.46-9.38-13.23
Upgrade
Change in Working Capital
-1.58-6.57-0.31.48-3.59
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.